Incidence of Gastrointestinal Perforation in Users of ACTEMRA® (Tocilizumab), Abatacept and Anti-Tumor Necrosis Factor Alpha Agents

23/11/2016
01/04/2024
EU PAS number:
EUPAS16143
Study
Finalised
Documents
Study protocol
No information provided.
Study results
No information provided.
Study report
No information provided.
ENCePP Seal
No information provided.